Company · CME
CME Group Inc.
Name as listed on its exchange; filed with the SEC as CME GROUP INC.
Nasdaq's symbol directory lists CME on Nasdaq as “CME Group Inc. - Class A Common Stock”.
In the 12 months to Nov 19, 2026: insiders bought on 2 occasions ($156K); insiders sold on 7 occasions ($9.7M); 8 planned-sale notices; 4 congressional trade disclosures; 5 company reports (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Terrence A. Duffy, Chairman and CEO sold $4.1M
- Julie Winkler, Sr MD Chief Commercial Officer sold $3.1M
- Sunil Cutinho, Chief Information Officer sold $1.5M
- SIEGEL HOWARD J sold $606K
- Kaye Daniel G sold $162K
- William R. Shepard bought $156K
- Cook Elizabeth A sold $140K
- GEPSMAN MARTIN J sold $121K
Every trade (9)
- SELLKaye Daniel G sold $162K
- SELLJulie Winkler, Sr MD Chief Commercial Officer sold $3.1M
- SELLSIEGEL HOWARD J sold $606K
- SELLSunil Cutinho, Chief Information Officer sold $1.5M
- SELLGEPSMAN MARTIN J sold $121K
- BUYWilliam R. Shepard bought $78K
- SELLCook Elizabeth A sold $140K
- SELLTerrence A. Duffy, Chairman and CEO sold $4.1M
- BUYWilliam R. Shepard bought $78K
Planned sales · SEC Form 144
Notice given
A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice
- Kaye Daniel G $163K
- JULIE WINKLER $3.1M
- SIEGEL HOWARD J $606K
- SUNIL CUTINHO $1.5M
- MARTIN J GEPSMAN $121K
- JONATHAN MARCUS $106K
- ELIZABETH ANNE COOK TRUST $140K
- Terrence Duffy $4.1M
Congress · STOCK Act
The Althing
Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.
- Gilbert Cisneros (D-CA31): Sale $1,001 - $15,000
- Alan Armstrong (R-OK): Purchase $1,001 - $15,000
- Gilbert Cisneros (D-CA31): Purchase $1,001 - $15,000
- Julie Johnson (D-TX32): Sale $1,001 - $15,000
Executive branch · OGE Form 278-T
Reported by the President
8 confirmed trades on scanned reports whose security name matches this company's own filed name exactly (letter case, punctuation and Inc/Corp-style endings aside). All of Donald J. Trump's reports
- Purchase: Cme Group Inc $15,001 – $50,000
- Sale: CME GROUP INC $50,001 – $100,000
- Sale: Cme Group Inc $15,001 – $50,000
- Sale: CME GROUP INC $500,001 – $1,000,000
- Sale: CME GROUP INC $100,001 – $250,000
- Purchase: CME GROUP INC $50,001 – $100,000
- Purchase: CME GROUP INC $100,001 – $250,000
- Purchase: CME GROUP INC $500,001 – $1,000,000
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Results of operations and financial condition Oct 21, 2026
- Amendments to articles or bylaws; change in fiscal year Sep 25, 2026
- Departure or appointment of directors or officers Sep 9, 2026
- Regulation FD disclosure Aug 11, 2026
- Results of operations and financial condition Jul 22, 2026
Lobbying · Senate LDA reports
Lobbying filed
6 quarterly lobbying reports for 2026 naming CME Group Inc. as the client: 2 filed by the company itself, 4 by outside firms it hired. Each line is one report as filed; an amended report is a line of its own. An outside firm states what the company paid it; the company's own report states its whole lobbying spend, which can include those fees, so the lines are not added up. Reports are collected in batches and a quarter can be missing here; the full record is at lda.gov.
- The company itself $620K
- OGR $60K
- THE RUSSELL GROUP, INC. $60K
- The company itself $430K
- OGR $60K
- THE RUSSELL GROUP, INC. $60K
Sources: SEC EDGAR (Forms 4, 144 and 8-K), Senate LDA lobbying reports, OGE Form 278-T reports on whitehouse.gov and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.